Keros Therapeutics Inc (KROS)
16.49
-0.22
(-1.32%)
USD |
NASDAQ |
Dec 26, 11:37
Keros Therapeutics Free Cash Flow: -142.50M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Aptevo Therapeutics Inc | -23.28M |
| Corcept Therapeutics Inc | 142.60M |
| Regeneron Pharmaceuticals Inc | 3.319B |
| Scholar Rock Holding Corp | -188.86M |
| Trevi Therapeutics Inc | -35.12M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -30.50M |
| Cash from Investing (Quarterly) | -0.386M |
| Cash from Financing (Quarterly) | 155.94M |
| Free Cash Flow Per Share (Quarterly) | -0.8216 |
| Free Cash Flow to Equity (Quarterly) | -30.89M |
| Free Cash Flow Yield | -24.78% |